Compare profiles
Side-by-side leveling, scope, and market pay. Add up to four via ?keys=SWE.GEN.P5,SWE.GEN.P6.
| vs | P1 PHARMA.PHARMACOA353.P1 Pharmacovigilance (Drug Safety) — P1 | P2 PHARMA.PHARMACOA353.P2 Pharmacovigilance (Drug Safety) — P2 | P3 PHARMA.PHARMACOA353.P3 Pharmacovigilance (Drug Safety) — P3 | P4 PHARMA.PHARMACOA353.P4 Pharmacovigilance (Drug Safety) — P4 |
|---|---|---|---|---|
| Market pay | $50k ($39k–$64k)inherited | $59k ($46k–$75k)inherited | $67k ($53k–$85k)inherited | $89k ($70k–$113k)inherited |
| Level | P1 · P1 — Entry-Level Professional | P2 · P2 — Developing Professional | P3 · P3 — Mid-Level Professional | P4 · P4 — Senior Professional |
| Function | Pharmacovigilance (Drug Safety) | Pharmacovigilance (Drug Safety) | Pharmacovigilance (Drug Safety) | Pharmacovigilance (Drug Safety) |
| Focus | Pharmacovigilance (Drug Safety) | Pharmacovigilance (Drug Safety) | Pharmacovigilance (Drug Safety) | Pharmacovigilance (Drug Safety) |
| Typical years | 0–2 | 1–3 | 3–5 | 5–8 |
| Scope | Own tasks within a defined component | Defined deliverables / small features | Features or a sub-system end-to-end | A system or set of related features |
| Autonomy | Close supervision; work reviewed frequently | General supervision; reviewed at milestones | Works independently on standard work; reviewed on the non-standard | Self-directed; reviewed at critical decision points |
| Impact | Own deliverables | Own and immediate-team deliverables | Project / team outcomes | Multi-team / function outcomes |
| Decision rights | Few independent decisions; escalates the rest | Routine technical choices within guidance | Owns implementation decisions for own scope | Owns technical decisions for a system; influences adjacent design |